What restriction applies to occlusive dressings when using the Glenmark Pharmaceuticals Europe Ltd mometasone furoate 0.1% w/w ointment product in children aged 2 years and older?

Occlusive dressings must not be used with the Glenmark Pharmaceuticals Europe Ltd mometasone furoate 0.1% w/w ointment product in children aged 2 years and older; treatment is limited to a maximum of 10% of body surface area and 3 weeks.